McKesson Corporation
MCK
#221
Rank
$104.541 B
Marketcap
United States
Country
$896.65
Share price
-0.57%
Change (1 day)
28.57%
Change (1 year)
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to…
Key Metrics
Trailing P/E
23.67
Forward P/E
17.48
EPS (TTM)
$37.27
Forward EPS
$50.47
Price / Book
—
EV / EBITDA
16.0x
Beta
0.31
Dividend Yield
0.42%
Return on Equity
—
Return on Assets
4.74%
Debt / Equity
—
Current Ratio
0.89
Gross Margin
3.63%
Operating Margin
1.35%
Net Profit Margin
1.12%
Free Cash Flow
$6.801B
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 18 – Sep 17
+1.49%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$403.430B
Latest Net Income$4.762B
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare McKesson Corporation with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
MCK
No recent news available. Set FINNHUB_API_KEY to enable news.
